SONNET BIOTHERAPEUTICS HOLDI (SONN) Stock Balance Sheet
NASDAQ:SONN • US83548R4020
Current stock price
1.26 USD
-1.84 (-59.35%)
At close:
1 USD
-0.26 (-20.63%)
After Hours:
| MRQ (2025-6-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 321.30K | 149.50K | 2.27M | 3.05M | 27.62M | |||
| Receivables | 597.40K | 762.10K | 786.60K | N/A | N/A | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 400.90K | 1.21M | 1.68M | 2.36M | 1.19M | |||
| Total Current Assets | 1.32M | 2.12M | 4.74M | 5.41M | 28.81M | |||
| Non-Current Assets | ||||||||
| PPE Net | 77.50K | 143.90K | 227.10K | 300.00K | 180.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 658.30K | 509.20K | 464.20K | 110.00K | 0.00 | |||
| Total Non-Current Assets | 735.70K | 653.10K | 691.30K | 420.00K | 180.00K | |||
| TOTAL ASSETS | 2.06M | 2.77M | 5.43M | 5.83M | 28.99M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 1.35M | 1.03M | 3.30M | 3.25M | 2.40M | |||
| Accounts Payable | 3.75M | 2.18M | 2.20M | 4.75M | 3.78M | |||
| Other Current Liabilities | N/A | N/A | 18.60K | 170.00K | 520.00K | |||
| Total Current Liabilities | 5.10M | 3.21M | 5.52M | 8.16M | 6.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 0.00 | 46.60K | 130.90K | 200.00K | 30.00K | |||
| Total Non-Current Liabilities | 0.00 | 46.60K | 130.90K | 210.00K | 30.00K | |||
| TOTAL LIABILITIES | 5.10M | 3.26M | 5.66M | 8.37M | 6.73M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -128.11M | -117.68M | -110.24M | -91.41M | -61.69M | |||
| Additional Paid In Capital | 125.06M | 117.20M | 110.02M | 88.87M | 83.94M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 300.00 | 100.00 | 200.00 | 0.00 | 10.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 3.33M | 650.30K | 218.80K | 250.00K | 200.00K | |||
| Tangible Book Value per Share | -0.91 | -0.75 | -1.03 | -10.16 | 111.30 | |||
| Total Shareholders' Equity | -3.05M | -485.70K | -226.00K | -2.54M | 22.26M | |||
| TOTAL LIABILITIES AND EQUITY | 2.06M | 2.77M | 5.43M | 5.83M | 28.99M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 0.26 | 0.66 | 0.86 | 0.66 | 4.30 | |||
| Return On Assets (ROA) | -659.57% | -268.39% | -346.86% | -509.78% | -86.17% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | -112.22% | |||
All data in USD , ROIC based on taxRate of 0.21